Chronic pain is common in individuals with severe and moderate haemophilia who did not receive prophylaxis during childhood

Approximately 35%-50% of people with haemophilia (PWH) report living with chronic musculoskeletal pain

Clotting factor replacement forms the pillar of treatment for children with hemophilia

Long noncoding RNAs (lncRNAs) are emerging as crucial contributors to the development of breast cancer and are involved in the stemness regulation of...

Despite a high prevalence of angiodysplasia, no specific guidelines are available for the modalities of endoscopic exploration of GI-bleeding in VWD

Adolescents and young adults (AYAs) with severe hemophilia use prophylaxis that requires a high level of adherence

Men with advanced prostate cancer (APC) face multiple challenges including poor prognosis, poor health- related quality of life (HRQOL), and elevated...

To analyse the role of repeated breast surgery (RBS) after breast conserving surgery (BCS) as a quality indicator in a consecutive series of breast...

Although a growing body of evidence supports an early-life contribution to prostate cancer development, few studies have investigated early-life diet

Long-acting products are changing the haemophilia A treatment landscape by giving patients and caregivers treatment options with varying product...

3D gait analysis has been proposed as a reproducible and valid method to assess abnormal gait patterns and to monitor disease progression in patients...